###begin article-title 0
Angiotensin-(1-7) and the G Protein-Coupled Receptor Mas Are Key Players in Renal Inflammation
###end article-title 0
###begin p 1
Conceived and designed the experiments: JE HPS MRO TW. Performed the experiments: VE SHW ASK RdB SvdE YW SM. Analyzed the data: VE SHW ASK RdB MRO.
###end p 1
###begin p 2
Angiotensin (Ang) II mediates pathophysiologial changes in the kidney. Ang-(1-7) by interacting with the G protein-coupled receptor Mas may also have important biological activities.
###end p 2
###begin p 3
###xml 209 213 <span type="species:ncbi:10090">mice</span>
In this study, renal deficiency for Mas diminished renal damage in models of renal insufficiency as unilateral ureteral obstruction and ischemia/reperfusion injury while the infusion of Ang-(1-7) to wild-type mice pronounced the pathological outcome by aggravating the inflammatory response. Mas deficiency inhibited NF-kappaB activation and thus the elevation of inflammation-stimulating cytokines, while Ang-(1-7) infusion had proinflammatory properties in experimental models of renal failure as well as under basal conditions. The Ang-(1-7)-mediated NF-kappaB activation was Mas dependent but did not involve Ang II receptors. Therefore, the blockade of the NF-kappaB-activating properties of the receptor Mas could be a new strategy in the therapy of failing kidney.
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 256 259 256 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Schoolwerth1">[1]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Thorp1">[2]</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients with chronic kidney diseases (CKD) represent a worldwide problem. The prevalence of CKD in the US population is around 11%, and because of the increase in diabetes, obesity and hypertension an exponential increase is predicted for the next decade [1], [2].
###end p 5
###begin p 6
###xml 199 202 199 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Wolf1">[3]</xref>
###xml 364 367 364 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RuizOrtega1">[4]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Casas1">[5]</xref>
###xml 559 562 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-MacKinnon1">[6]</xref>
###xml 177 182 <span type="species:ncbi:9606">human</span>
The activation of the renal renin angiotensin system (RAS), characterized by elevated ACE expression and increased local angiotensin (Ang) II production, has been found in many human kidney diseases [3]. Ang II, the main peptide of RAS, is a true cytokine that regulates cell growth, inflammation and fibrosis and therefore contributes to renal damage progression [4]. Blockade of Ang II actions, by ACE inhibitors or AT1 antagonists, is one of the current therapeutic strategies with proven beneficial effects in the treatment of chronic renal diseases [5], [6].
###end p 6
###begin p 7
###xml 123 126 123 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferrario1">[7]</xref>
###xml 286 289 286 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferrario2">[8]</xref>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 481 484 481 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Santos1">[9]</xref>
###xml 486 490 486 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Tallant1">[10]</xref>
###xml 662 666 662 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Alenina1">[11]</xref>
###xml 695 698 695 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 743 747 743 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Jackson1">[12]</xref>
###xml 816 818 816 818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 837 840 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ambroz1">[13]</xref>
###xml 969 973 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Kostenis1">[14]</xref>
###xml 328 332 <span type="species:ncbi:10090">mice</span>
Besides Ang II, other Ang peptides, such as Ang IV [Ang-(3-8)] and Ang-(1-7) may also have important biological activities [7]. Especially, Ang-(1-7) has become an angiotensin of interest in the past few years, since its cardiovascular and baroreflex actions counteract those of Ang II [8]. Studies from our group and others in mice deficient for the G protein-coupled receptor Mas and cell transfection experiments gave evidence that Mas codes for a functional Ang-(1-7) receptor [9], [10], that is expressed predominantly in testis and in distinct areas of fore-brain such as the hippocampus and amygdada and, less strongly but detectable, in kidney and heart [11]. First suggestions that the Mas gene codes for an Ang II-sensitive receptor [12] have been corrected by findings that alterations in intracellular Ca2+-concentrations in Mas-transfected cells after Ang II treatment could only be confirmed in cells expressing the Ang II receptor AT1 endogenously [13], [14].
###end p 7
###begin p 8
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 161 165 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Walther1">[15]</xref>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Walther2">[16]</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient for the Mas protooncogene present a sustained long-term potentiation in hippocampal neurons and sex-specific alterations in exploratory behaviour [15] and heart rate and blood pressure variability were observed [16].
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Disease evolution in Mas-deficient mice following unilateral ureteral obstruction
###end title 10
###begin p 11
###xml 158 162 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Klahr1">[17]</xref>
###xml 214 215 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 221 222 217 218 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 276 280 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 281 285 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ma1">[19]</xref>
The unilateral ureteral obstruction (UUO) model is characterized by interstitial inflammatory cell infiltration, NF-kappaB activation, apoptosis and fibrosis [17]. Many studies have demonstrated that Ang II, via AT1 or AT2 receptors, contributes to renal damage following UUO [18]-[19].
###end p 11
###begin p 12
###xml 70 74 70 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Langeveld1">[21]</xref>
###xml 76 80 76 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Loot1">[22]</xref>
###xml 157 161 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Burgelova1">[23]</xref>
###xml 163 167 163 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferreira1">[24]</xref>
###xml 755 759 755 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 854 863 854 863 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1A</bold>
###xml 854 863 854 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1A</bold></xref>
###xml 863 876 863 876 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, lower panel</bold>
###xml 1006 1015 1006 1015 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1B</bold>
###xml 1006 1015 1006 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1B</bold></xref>
###xml 1261 1270 1261 1270 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1261 1270 1261 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1C</bold></xref>
###xml 1423 1432 1423 1432 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1C</bold>
###xml 1423 1432 1423 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1C</bold></xref>
###xml 1687 1690 1687 1690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 1768 1777 1768 1777 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1D</bold>
###xml 1768 1777 1768 1777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1D</bold></xref>
###xml 319 323 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1742 1746 <span type="species:ncbi:10090">mice</span>
As Ang-(1-7) has been shown to have protective cardiovascular effects [21], [22] and this heptapeptide has been also described to have effects in the kidney [23], [24], we investigated effects of deficiency in the Mas receptor associated to Ang-(1-7) signaling in the UUO model. Thus, UUO was performed in Mas-knockout mice (Mas-/-) and their wild-type controls (Mas+/+) and kidneys were studied after 2, 5 and 7 days. The contralateral kidneys of Mas-deficient animals showed no histological alterations and did not differ from contralateral wild-type kidneys. Masson staining of kidney sections two days after UUO showed occasional perivascular mononuclear cell infiltrates and tubular damage in wild-type kidneys, congruent to our previous description [18], while obstructed kidneys lacking Mas showed no inflammatory infiltrates and tubular lesions (Figure 1A, lower panel). Wild-type UUO kidneys revealed prominent perivascular, interstitial matrix deposition that was less pronounced in Mas-/- mice (Figure 1B, blue staining). This difference further increased at the endpoint of 7 days, when wild-type kidneys showed pronounced infiltration of cells in the interstitium and fibrosis while much less stained cells in the knockout kidneys were detectable (Figure 1C). Notably, the UUO kidneys with Mas receptors showed occasional glomerular collapse (arrowheads) that was not observed in kidneys lacking the receptor (Figure 1C). Glomerular pathology was quantified by counting the glomeruli with pathomorphological lesions such as collapse, matrix deposition, microthrombi and cellular infiltrates. The number of glomeruli with pathomorphological changes was significantly less in Mas-deficient UUO kidneys than in kidneys of wild-type mice after 5 days of UUO (Figure 1D).
###end p 12
###begin title 13
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Evolution of renal lesions in the model of unilateral ureteral obstruction (UUO) in Mas-deficient and wild-type mice.
###end title 13
###begin p 14
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 932 933 930 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 987 988 985 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1486 1487 1484 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1596 1597 1592 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1652 1653 1648 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1703 1704 1688 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 1721 1725 <span type="species:ncbi:10090">mice</span>
###xml 1826 1830 <span type="species:ncbi:10090">mice</span>
UUO was set in Mas-deficient (Mas-/-) mice and their wild-type controls (Mas+/+), and animals were studied after 2, 5 and 7 days; Masson staining (A) and Azan blue (B) after 2 days and Masson staining after 7 days (C), respectively; magnification: 100x, 200x and 100x, respectively. (D) Shows the quantification of glomeruli with pathomorphological lesions such as collapse, matrix deposition, microthrombi and cellular infiltrates, in UUO kidneys of Mas-deficient mice and their wild-type controls. (E) Demonstrates lower concentrations of blood urea nitrogen in Mas-deficient mice 2 days after UUO. (F) Shows evaluation of apoptosis-related proteins at 2 days of UUO. Data of renal Bax/Bcl-xl ratio expressed as n-fold of increase vs. contralateral kidneys of each genotype, expressed as mean+/-SEM of 6-8 animals per group. Open and black bars represent Mas+/+ or Mas-/-, respectively; C: contralateral, O: obstructed kidneys; * P<0.05 vs. contralateral kidney of its own genotype; # P<0.05 vs. Mas+/+ obstructed kidney. (G) Shows the computer analysis of monocytes/macrophages scoring 2, 5 and 7 days of UUO. The presence of inflammatory cell infiltration was determined by immunohistochemistry with anti-F4/80 antibody (specific for monocytes/macrophages; brown staining); magnification: 200x. There were no differences between the number of monocytes/macrophages in contralateral kidneys at 2, 5 and 7 days of UUO (data not shown). Results are expressed as F4/80 positive cells/mm2 as mean+/-SEM of 6-10 animals per group. Open bars show data of Mas +/+ and black bars of Mas-/- kidneys, * P<0.05 vs. contralateral kidney of the same genotype; # P<0.05 vs. Mas+/+ obstructed kidneys; section sign P<0.05 vs. Mas+/+ mice. (H) Illustrates inflammatory cell infiltration in obstructed kidneys (cortex) of Mas+/+ and Mas-/- mice (representative kidneys of 6-10 studied in each genotype, each time point).
###end p 14
###begin p 15
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 182 191 182 191 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1E</bold>
###xml 182 191 182 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1E</bold></xref>
###xml 203 217 203 217 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 367 381 367 381 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
Importantly, the significant less renal damage after UUO in Mas-deficient mice led also to a preserved renal function compared to wild-type mice with UUO. Blood urea nitrogen (BUN) (Figure 1E) and urea (data not shown) were significant less in mice with Mas deficiency two days after UUO. Notably, under sham conditions both strains did not differ in renal function (data not shown).
###end p 15
###begin p 16
###xml 555 564 555 564 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1F</bold>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1F</bold></xref>
###xml 425 429 <span type="species:ncbi:10090">mice</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
Since these results suggested that the absence of the receptor Mas prevents renal disease progression in the UUO model, we next examined the expression of apoptosis-related proteins that promote (Bax) or protect (Bcl-xL) from cell death. Two days after UUO, the Bax/Bcl-xL ratio increased in the obstructed kidneys of both genotypes in comparison to the contra-lateral control kidneys but significantly less in Mas-deficient mice. This less pronounced increase in the Bax/Bcl-xL ratio in UUO-kidneys of Mas-/- mice implicated induction of less apoptosis (Figure 1F).
###end p 16
###begin p 17
###xml 306 320 306 320 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 548 557 548 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1G</bold>
###xml 548 557 548 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1G</bold></xref>
###xml 557 559 557 559 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">; </bold>
###xml 559 568 559 568 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1H</bold>
###xml 559 568 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1H</bold></xref>
###xml 568 582 568 582 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, upper panels</bold>
###xml 681 690 681 690 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1G</bold>
###xml 681 690 681 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1G</bold></xref>
###xml 690 692 690 692 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">; </bold>
###xml 692 701 692 701 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1H</bold>
###xml 692 701 692 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1H</bold></xref>
###xml 701 715 701 715 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, lower panels</bold>
###xml 876 885 876 885 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1G</bold>
###xml 876 885 876 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1G</bold></xref>
###xml 885 887 885 887 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">; </bold>
###xml 887 896 887 896 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1H</bold>
###xml 887 896 887 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1H</bold></xref>
###xml 896 910 896 910 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, right panels</bold>
###xml 171 177 <span type="species:ncbi:10090">murine</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
To dissect the inflammatory response in this model, we examined inflammatory cell infiltration by immunohistochemistry with a specific anti-F4/80 antibody that recognizes murine monocytes/macrophages. In control samples and in non-injured kidneys of both genotypes, only few cells were positive for F4/80 (data not shown). Two and five days after UUO, obstructed kidneys of Mas+/+ mice showed scattered infiltrates of mononuclear cells within interstitial spaces focally distributed mainly at juxtamedular level, compared to contralateral kidneys (Figure 1G; Figure 1H, upper panels). Obstructed kidneys of Mas-deficient mice lacked this pronounced increase in infiltrating cells (Figure 1G; Figure 1H, lower panels). After 7 days of UUO, the presence of monocytes/macrophages infiltrates in Mas-deficient kidneys was significantly lower than in obstructed wild-type kidneys (Figure 1G; Figure 1H, right panels). This clearly supports our data that renal Mas deficiency retards UUO damage progression.
###end p 17
###begin title 18
Ang-(1-7) worsens the renal lesions following unilateral ureteral obstruction
###end title 18
###begin p 19
###xml 529 538 529 538 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 1F</bold>
###xml 529 538 529 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g001"><bold>Figure 1F</bold></xref>
###xml 613 622 613 622 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2A</bold>
###xml 613 622 613 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2A</bold></xref>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 313 317 <span type="species:ncbi:10090">mice</span>
If the beneficial effects of Mas deficiency were related to the lacking interaction of Ang-(1-7) with its signaling-associated receptor, detrimental effects of the heptapeptide via Mas on the UUO-initiated pathology in wild-type mice had to be anticipated. Therefore, UUO was performed in two groups of wild-type mice, one receiving Ang-(1-7) through a subcutaneously placed minipump, the other one saline. While Mas deficiency reduced the induction of changes in the ratio of pro-/anti-apoptotic proteins in obstructed kidneys (Figure 1F), the infusion of Ang-(1-7) significantly pronounced apoptotic processes (Figure 2A). This detrimental effect was already manifest at the second day post surgery and even more significant after 5 days.
###end p 19
###begin title 20
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Effect of Ang-(1-7) treatment on apoptosis, fibrosis and inflammatory processes in wild-type mice with unilateral ureteral obstruction (UUO).
###end title 20
###begin p 21
###xml 1665 1666 1647 1648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1721 1722 1703 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1762 1763 1742 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 347 351 <span type="species:ncbi:10090">mice</span>
###xml 784 788 <span type="species:ncbi:10090">mice</span>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
Wild-type mice underwent UUO and were treated with Ang-(1-7) or saline (systemic infusion by osmotic minipumps). (A) A representative western blot showing renal Bax and Bcl-xL expression (upper panel) and the calculation of the Bax/Bcl-xl ratio (lower panel) after 5 days of UUO. Open and black bars represent data of saline- or Ang-(1-7)-infused mice, respectively, expressed as mean+/-SEM of 6 animals per group. Figures B and C show representative kidney sections (B: cortex with glomerulus; C: medulla) with van Gieson staining and anti-F4/80 immunostaining, respectively (positive immunoreactivity reveals brown signal [arrowheads]). Magnification: 400x. (D) Infiltrating leukocytes were counted based on their morphology and location within renal cortex, medulla, and pelvis in mice infused with saline or Ang-(1-7). (E) Renal NF-kappaB activation was measured in wild-type mice infused with saline or Ang-(1-7) and in Mas-deficient mice (Mas-/-) and their respective wild-type controls (Mas+/+) at 2 and 5 days of UUO. The figure shows data of renal NF-kappaB activity expressed as n-fold increase vs. contralateral kidney as mean+/-SEM of 6 animals per group analyzed in duplicate. (F) Shows a representative EMSA experiment. Competition assay with a 100-fold excess of unlabeled NF-kappaB shows the specificity of the binding (marked by arrows). The position of free oligonucleotides is indicated. (G) Shows data of gene expression of proinflammatory factors (MCP-1 and IL-6) obtained by real-time PCR experiments and expressed as n-fold increase vs. contralateral kidney as mean+/-SEM of 8-10 animals per group; C: contralateral, O: obstructed kidneys. * P<0.05 vs. contralateral kidney of the same genotype; # P<0.05 vs. Mas+/+ obstructed kidney; yen P<0.05 vs. saline-infused obstructed kidneys.
###end p 21
###begin p 22
###xml 224 233 224 233 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2B</bold>
###xml 224 233 224 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2B</bold></xref>
###xml 596 597 592 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
Histological evaluation identified in UUO kidneys of Ang-(1-7)-treated wild-type mice an increase in matrix deposition in the mesangial area (blue staining) in comparison to obstructed kidneys of the saline-treated animals (Figure 2B). The number of glomeruli with pathomorphological changes was significantly more in UUO kidneys of mice treated with Ang-(1-7) than in kidneys of saline-treated animals after 5 days of UUO (UUO wild-type saline: 5.7+/-0.8 glomeruli with pathomorphological changes per HPF and UUO wild-type Ang-(1-7): 9.9+/-2.0 glomeruli with pathomorphological changes per HPF; P<0.05).
###end p 22
###begin p 23
###xml 196 205 196 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2C</bold>
###xml 196 205 196 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2C</bold></xref>
###xml 722 731 722 731 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2D</bold>
###xml 722 731 722 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2D</bold></xref>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
To investigate whether the more severe phenotype related to an Ang-(1-7) infusion led also to more pronounced inflammation, F4/80-positive cells were stained (exemplarily shown for the medulla in Figure 2C). The saline group showed only occasional infiltration of inflammatory cells within interstitial areas (arrowheads). However, there was a marked increase of mononuclear cells in interstitial area in the Ang-(1-7)-infused group implicating more inflammation. This pronounced inflammation was also supported by quantitative analysis counting infiltrating leukocytes. The UUO kidneys of mice that received Ang-(1-7) showed significantly more leukocyte infiltration than the UUO kidneys from the saline treated animals (Figure 2D).
###end p 23
###begin p 24
###xml 431 446 423 438 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2E and F</bold>
###xml 431 446 423 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2E and F</bold></xref>
###xml 223 227 <span type="species:ncbi:10090">mice</span>
###xml 400 404 <span type="species:ncbi:10090">mice</span>
To follow the hypothesis that Mas deficiency prevents, and Ang-(1-7) stimulates inflammation we next checked for NF-kappaB activation. UUO significantly increased renal NF-kappaB activity in saline-treated and Mas-wildtype mice (obstructed vs. contralateral kidney). Confirming our immunohistological data, this activation was even more pronounced by Ang-(1-7) treatment but significantly reduced in mice lacking the Mas receptor (Figure 2E and F).
###end p 24
###begin p 25
###xml 88 92 84 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Inan1">[25]</xref>
###xml 94 98 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RuizOrtega2">[26]</xref>
###xml 218 221 210 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Wolf1">[3]</xref>
###xml 223 227 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Inan1">[25]</xref>
###xml 228 232 220 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Mezzano1">[27]</xref>
###xml 544 547 520 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RuizOrtega1">[4]</xref>
###xml 549 553 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 555 559 531 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RuizOrtega2">[26]</xref>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 272 278 <span type="species:ncbi:9606">humans</span>
NF-kappaB is a pivotal transcription factor in chronic immune and inflammatory diseases [25], [26]. In human kidney diseases elevated renal NF-kappaB activity correlates with upregulation of proinflammatory parameters [3], [25]-[27]. Although there are no current data in humans, many experimental models have shown that NF-kappaB blockade (by different maneuvers, including IkappaB overexpression, NF-kappaB decoy oligonucleotides, NF-kappaB inhibitors, ACE inhibition, statins, glucocorticoids and antioxidants) attenuates renal inflammation [4], [18], [26].
###end p 25
###begin p 26
###xml 219 223 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 532 541 520 529 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2G</bold>
###xml 532 541 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2G</bold></xref>
###xml 567 571 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 790 799 778 787 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 2G</bold>
###xml 790 799 778 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figure 2G</bold></xref>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
###xml 762 766 <span type="species:ncbi:10090">mice</span>
We recently described for the UUO model that two different NF-kappaB inhibitors, PDTC and parthenolide, diminished the inflammatory cell infiltration and downregulated gene expression of several proinflammatory factors [18]. Thus, we further investigated whether NF-kappaB downstream signaling was also influenced by alterations in the Ang-(1-7)/Mas axis. Obstructed kidneys of wildtype mice showed increased mRNA expression of proinflammatory cytokines (TNF-alpha, IL-6), and chemokines (MCP-1) compared to the contralateral ones (Figure 2G) as previously described [18]. Ang-(1-7) infusion further increased IL-6 and MCP-1 mRNA concentrations, while in Mas-deficient mice, obstructed kidneys presented significant less gene activation compared to Mas-wildtype mice, both at 2 and 5 days (Figure 2G). Thus, the combination of results taken from immunohistochemistry and molecular biological techniques consistently proves that Ang-(1-7) is a proinflammatory peptide whose actions are abrogated in the absence of the receptor Mas.
###end p 26
###begin title 27
Impact of Mas and Ang-(1-7) on renal ischemia/reperfusion injury
###end title 27
###begin p 28
###xml 397 401 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Alcazar1">[28]</xref>
Following these results in the UUO model, we set out to investigate whether the effects on NF-kappaB regulation by Ang-(1-7) and Mas are restricted to the UUO model or also act in other models of renal inflammation. We thus introduced a second experimental kidney model that is characterized by an inflammatory component. Since renal ischemia is a major cause of acute and end-stage renal failure [28], producing serious morbidity and mortality, renal ischemia/reperfusion (I/R) injury was chosen to evaluate whether Ang-(1-7) and Mas was involved in the primary mechanisms determining ischemia-mediated renal failure.
###end p 28
###begin p 29
###xml 175 190 175 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A and B</bold>
###xml 175 190 175 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3A and B</bold></xref>
###xml 273 282 273 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 273 282 273 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3B</bold></xref>
###xml 530 545 530 545 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A and B</bold>
###xml 530 545 530 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3A and B</bold></xref>
###xml 742 751 742 751 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3B</bold>
###xml 742 751 742 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3B</bold></xref>
###xml 1041 1056 1041 1056 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3A and B</bold>
###xml 1041 1056 1041 1056 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3A and B</bold></xref>
###xml 1529 1530 1525 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1766 1767 1758 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 1266 1270 <span type="species:ncbi:10090">mice</span>
In wild-type animals (I/R saline and I/R Mas+/+), renal ischemia/reperfusion led to diffuse matrix deposition as well as partial glomerular collapse 3 days after reperfusion (Figure 3A and B, first and third panels). Furthermore, reduced glomerular perfusion was detected (Figure 3B, first and third panels). Compared to these findings, I/R kidneys of mice infused with Ang-(1-7) showed more dramatic tissue destruction as characterized by marked infiltrates of mixed inflammatory cells and more severe diffuse matrix deposition (Figure 3A and B, second panel). These kidneys were also characterized by intraglomerular protein precipitates (arrowheads), increased cellularity, and more reduced glomerular perfusion in glomerular capillaries (Figure 3B, second panel). In contrast to the more severe pathomorphological changes in the I/R-Ang-(1-7) group, Mas-deficient kidneys showed no evidence of matrix deposition in the renal parenchyma 3 days post ischemia. Notably, there were also significant less structural changes in the glomeruli (Figure 3A and B, forth panel). The protective effect of Mas deficiency was also illustrated by the number of glomeruli with pathomorphological changes. The number of altered glomeruli was significantly more in I/R kidneys of mice treated with Ang-(1-7) than in kidneys of saline-treated animals after 3 days of I/R (I/R wild-type saline: 2.8+/-0.3 glomeruli with pathomorphological changes per HPF and I/R wild-type Ang-(1-7): 4.3+/-0.4 glomeruli with pathomorphological changes per HPF; P<0.01), whereas it was less in Mas-deficient kidneys compared to their wild-type (I/R wild-type: 4.3+/-0.4 glomeruli with pathomorphological changes per HPF and I/R knockout: 2.3+/-0.3 glomeruli with pathomorphological changes per HPF; P<0.001).
###end p 29
###begin title 30
Impact of Mas and Ang-(1-7) on renal lesions in the model of ischemia/reperfusion (I/R).
###end title 30
###begin p 31
###xml 798 799 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 832 833 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1046 1047 1030 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1080 1081 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 105 109 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 824 828 <span type="species:ncbi:10090">mice</span>
###xml 850 854 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:10090">mice</span>
###xml 1098 1102 <span type="species:ncbi:10090">mice</span>
I/R was performed in wild-type mice infused with saline (I/R Saline) or Ang-(1-7) (I/R Ang-(1-7)) and in mice deficient for Mas (I/R Mas-/-) and their wild-type controls (I/R Mas+/+). Animals were studied 3 days after I/R. Figures A and B show Ladewig and PAS staining respectively of group-representing renal sections. Magnification: 400x. (C) Infiltrating leukocytes were counted based on their morphology and location within renal cortex, medulla, and pelvis in mice infused with saline or Ang-(1-7) and in wild-type (Mas+/+) and Mas-deficient mice (Mas-/-). Renal NF-kappaB activity after I/R was measured by EMSA (D) and calculated (E) as renal NF-kappaB activity expressed as n-fold increase vs. wild-type controls and shown as mean+/-SEM of 6-10 animals per group analyzed in duplicate. yen P<0.05 vs. saline-infused mice; # P<0.05 vs. Mas+/+ mice. The right diagram (F) shows mRNA levels of MCP-1 and IL-6 expressed as n-fold increase vs. wild-type controls and expressed as mean+/-SEM of 6-8 animals per group analyzed in duplicate. yen P<0.05 vs. saline-infused mice; # P<0.05 vs. Mas+/+ mice.
###end p 31
###begin p 32
###xml 238 247 238 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003">Figure 3C</xref>
###xml 424 433 424 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3C</bold>
###xml 424 433 424 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3C</bold></xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
Next, the number of infiltrating leukocytes has been calculated. In I/R kidneys from Ang-(1-7)-treated mice the number of infiltrating leukocytes was significantly more than counted in I/R kidneys from wild-type mice treated with saline (Figure 3C). In contrast, in kidneys from Mas-deficient mice the number of infiltrating leukocytes was less than one quarter of that counted in I/R kidneys from their wild-type controls (Figure 3C).
###end p 32
###begin p 33
###xml 137 152 133 148 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D and E</bold>
###xml 137 152 133 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3D and E</bold></xref>
###xml 257 266 253 262 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3F</bold>
###xml 257 266 253 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3F</bold></xref>
###xml 509 520 501 512 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 3D&#8211;F</bold>
###xml 509 520 501 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>Figure 3D&#8211;F</bold></xref>
As in the UUO model, Ang-(1-7) infusion increased renal NF-kappaB activation in comparison to the I/R kidneys of saline-infused animals (Figure 3D and E). This was paralleled by significant higher mRNA levels of the proinflammatory cytokines MCP1 and IL-6 (Figure 3F). In contrast, the strong beneficial impact of the lack of the Mas receptor on I/R-induced pathomorphological changes was congruent with less NF-kappaB activation and significant lower renal mRNA of cytokines with proinflammatory properties (Figure 3D-F).
###end p 33
###begin title 34
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Systemic infusion of Ang-(1-7) into healthy mice induces renal inflammation requiring the Mas receptor
###end title 34
###begin p 35
###xml 523 532 523 532 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 523 532 523 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4A</bold></xref>
###xml 665 674 665 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 665 674 665 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4A</bold></xref>
###xml 842 851 842 851 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 842 851 842 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4A</bold></xref>
###xml 1091 1100 1091 1100 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 1091 1100 1091 1100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4B</bold></xref>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 708 712 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
To evaluate whether the proinflammatory effects of Ang-(1-7) are depending on a predisposition in failing kidney due to the pathophysiological stimulus or whether elevated circulating Ang-(1-7) concentrations induce renal inflammation already under basal conditions, we administered the heptapeptide to healthy wild-type mice. Systemic minipump infusion of Ang-(1-7) into normal control mice for 5 days caused an important increase in the number of monocytes/macrophages in the interstitium, distributed in a focal manner (Figure 4A, upper row). This heptapeptide-mediated increase was completely blocked by co-infusion with A779, an Ang-(1-7) receptor antagonist (Figure 4A, upper row), or in Mas-deficient mice. In kidneys of the latter one there were no infiltrating cells detectable, showing similar staining than in saline-infused mice (Figure 4A, second row). These results clearly demonstrate the proinflammatory properties of Ang-(1-7) under physiological conditions and that the presence of inflammatory cells in kidneys of animals infused with Ang-(1-7) requires the Mas receptor (Figure 4B).
###end p 35
###begin title 36
Angiotensin-(1-7) induces inflammatory cell infiltration under physiological conditions.
###end title 36
###begin p 37
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 501 502 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 774 775 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 820 821 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 858 859 850 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 896 897 886 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
Mas-deficient mice (Mas-/-) and mice deficient in all three Ang II receptors (AT1A, AT1B and AT2 = TKO) and their wild-type controls (Mas+/+ and TWT) were infused with Ang-(1-7) or saline for 5 days. Part of the Ang-(1-7)-infused mice were co-treated with the specific Ang-(1-7)-antagonist A779. A shows representative kidney slices stained by anti F4/80 antibody of each group and B summarizes the computer analysis of the monocytes/macrophages score. Results are expressed as F4/80 positive cells/mm2 as mean+/-SEM of 6-10 animals per group. (C) NF-kappaB data of densitometric analysis of EMSA experiments expressed as mean+/-SEM of 6-10 animals per group analyzed in duplicate were performed in all 4 investigated genotypes under the three different treatment regimes. *P<0.05 vs. saline-infused of each genotype, # P<0.05 vs Ang-(1-7)-infused Mas+/+. T P<0.05 vs. Ang-(1-7)-infused TWT. psi P<0.05 vs. Ang-(1-7)-infused TKO.
###end p 37
###begin p 38
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferrario1">[7]</xref>
###xml 155 158 155 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferrario2">[8]</xref>
###xml 307 311 307 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Gembardt1">[29]</xref>
###xml 602 611 602 611 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4A</bold>
###xml 602 611 602 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4A</bold></xref>
###xml 634 643 634 643 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4B</bold>
###xml 634 643 634 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4B</bold></xref>
###xml 187 191 <span type="species:ncbi:10090">mice</span>
###xml 770 774 <span type="species:ncbi:10090">mice</span>
###xml 798 802 <span type="species:ncbi:10090">mice</span>
Since there is controversy on the impact of the Ang II receptors AT1 (in rodents two isoforms: AT1A and AT1B) and AT2 on Ang-(1-7)-mediated signaling [7], [8], we used recently generated mice deficient in all three Ang II receptors (triple knockout, TKO) and their wild-type controls (triple wildtype, TWT) [29] to evaluate whether the proinflammatory properties of Ang-(1-7) depend on the expression of Ang II receptors. In both, TKO and TWT, infusion of Ang-(1-7) induces the presence of inflammatory cells, without differences between genotypes, showing that this effect is AT1 and AT2 independent (Figure 4A, third and lower row, Figure 4B). Notably, the observed effect that A779 treatment significantly diminishes inflammatory cells in Ang-(1-7)-infused wild-type mice was still preserved in mice deficient for all three Ang II receptors.
###end p 38
###begin title 39
Activation of renal NF-kappaB by angiotensin-(1-7) infusion requires the Mas receptor
###end title 39
###begin p 40
###xml 315 324 307 316 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 315 324 307 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4C</bold></xref>
###xml 379 393 371 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 498 501 486 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 703 712 687 696 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 4C</bold>
###xml 703 712 687 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>Figure 4C</bold></xref>
###xml 774 781 758 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 292 296 <span type="species:ncbi:10090">mice</span>
###xml 511 515 <span type="species:ncbi:10090">mice</span>
To link the increased staining of F4/80-positive cells after Ang-(1-7) infusion to molecular mechanisms, NF-kappaB activation was detected in the kidneys of the investigated groups. Systemic infusion of Ang-(1-7) for 5 days increased NF-kappaB DNA-binding activity in the kidney of wild-type mice (Mas+/+ and TWT) (Figure 4C) and stimulated release of proinflammatory cytokines (data not shown). Congruent with the immunohistochemical findings, there was no increase in renal NF-kappaB activity in Mas knockout mice infused with Ang-(1-7). Pharmacological blockade of Mas by treatment with A779 significantly diminished renal NF-kappaB activation in response to Ang-(1-7) infusion in wild-type strains (Figure 4C). Together, our findings provide robust proof that Ang-(1-7) in vivo under non-pathological circumstances initiates renal inflammation by activating the NF-kappaB pathway. This activation by Ang-(1-7) requires Mas but does not depend on any of the Ang II receptors.
###end p 40
###begin title 41
Ang-(1-7) activates the NF-kappaB pathway in cultured tubulo-epithelial cells
###end title 41
###begin p 42
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 370 379 362 371 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5A</bold>
###xml 370 379 362 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g005"><bold>Figure 5A</bold></xref>
###xml 399 401 391 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 595 605 583 593 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figures 2D</bold>
###xml 595 605 583 593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g002"><bold>Figures 2D</bold></xref>
###xml 605 607 593 595 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">, </bold>
###xml 607 609 595 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3C</bold>
###xml 607 609 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g003"><bold>3C</bold></xref>
###xml 609 614 597 602 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> and </bold>
###xml 614 616 602 604 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4C</bold>
###xml 614 616 602 604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g004"><bold>4C</bold></xref>
###xml 817 819 801 803 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 837 838 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 853 862 837 846 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 853 862 837 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g005"><bold>Figure 5B</bold></xref>
###xml 908 922 892 906 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 1005 1019 985 999 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 211 216 <span type="species:ncbi:10090">mouse</span>
We performed additional in vitro studies to visualize the postulated proinflammatory pathway stimulated by Ang-(1-7). At first we visualized the stimulation of NF-kappaB translocation to the nucleus in cultured mouse tubuloepithelial cells. In control cells a diffuse cytoplasmic immunofluorescence was seen with antibodies against the p65 or p50 subunits of NF-kappaB (Figure 5A). Treatment with 10-7 mol/L Ang-(1-7) for one hour led to an intense nuclear fluorescence with both antibodies, proofing nuclear translocation of NF-kappaB independent of the EMSA technique we used in renal tissue (Figures 2D, 3C and 4C). Importantly, the EMSA technique confirmed the immunofluorescence data in growth-arrested tubuloepithelial cells. Ang-(1-7) augmented NF-kappaB DNA-binding activity after 30 min being maximal with 10-7 mol/L after 1 h (P<0.05, n = 4) (Figure 5B) and diminished to control levels at 90 min (data not shown). Notably, NF-kappaB activation by Ang-(1-7) was blocked in the presence of A779 (data not shown).
###end p 42
###begin title 43
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Ang-(1-7) induces nuclear localization of p65 and p50 and proinflammatory cytokines in cultured mouse tubuloepithelial cells.
###end title 43
###begin p 44
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 525 527 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 829 830 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 898 900 880 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
###xml 1070 1071 1046 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 163 168 <span type="species:ncbi:10090">mouse</span>
(A) Growth arrested cells were treated with 10-7 mol/L Ang-(1-7) and AngII for 1 hour and p65 and p50 subunits were detected by an indirect immunostaining using a mouse FITC-labeled secondary antibody (green staining). Nuclei were stained with propidium iodure (in red). In the merge, the yellow staining shows nuclear localization of the NF-kappaB proteins after Ang-(1-7) stimulation. The results are representative of 3 independent observations done by confocal microscopy. (B) Growth arrested cells were incubated with 10-7 mol/L Ang-(1-7), AngII or TNFalpha for 1 hour. Thereafter, nuclear extracts were isolated and NF-kappaB activity was determined by binding assay with a labeled NF-kappaB oligonucleotide and analyzed by EMSA. Data are expressed as an n-fold increase vs. control cells, as mean+/-SEM of 4 experiments. *P<0.05 vs. control. (C) Growth arrested cells were stimulated with 10-7 mol/L Ang-(1-7) or TNFalpha for 18 and 24 hours. Gene expression of MCP-1 and IL-6 was analyzed by real-time PCR. Results are expressed as mean+/-SEM of 4 experiments. *P<0.05 vs. control.
###end p 44
###begin p 45
###xml 173 177 161 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RuizOrtega2">[26]</xref>
###xml 318 327 302 311 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5B</bold>
###xml 318 327 302 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g005"><bold>Figure 5B</bold></xref>
To better quantify the potency of Ang-(1-7)-mediated NF-kappaB activation, we compared it to the well-known and powerful NF-kappaB-activating ability of Ang II and TNFalpha [26]. Augmentation of NF-kappaB DNA-binding activity by Ang-(1-7) was in the same range as that for the two very potent proinflammatory factors (Figure 5B), illustrating a possible importance of the heptapeptide-mediated stimulation of inflammatory processes in renal diseases.
###end p 45
###begin p 46
###xml 99 107 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 320 329 312 321 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure 5C</bold>
###xml 320 329 312 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005406-g005"><bold>Figure 5C</bold></xref>
To evaluate whether Ang-(1-7) also regulates proinflammatory factors under NF-kappaB-control under in vitro conditions, and is also here comparably potent as TNFalpha, mRNA of proinflammatory factors was quantified. Ang-(1-7) upregulated gene expression of the cytokine IL-6 and the chemokine MCP-1 at both 18 and 24 h (Figure 5C) and this stimulation was comparable to the one induced by TNFalpha.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 96 99 96 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ferrario2">[8]</xref>
###xml 101 105 101 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Langeveld1">[21]</xref>
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Loot1">[22]</xref>
###xml 194 198 194 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Iwata1">[30]</xref>
Over the last decade, evidence accumulated that Ang-(1-7) has cardiovascular protective effects [8], [21], [22] and counteracts detrimental effects of Ang II under pathophysiological conditions [30]. These effects may relate to the heptapeptide's ability of vasorelaxation post myocardial infarction and its blood pressure-lowing effects under hypertensive conditions. However, all data presented here identify Ang-(1-7) and Mas to have also significant impact on renal inflammation and thus may have decisive properties in the pathogenesis and progression of renal failure. Their proinflammatory properties, being equally potent as the stimulatory capacity of Ang II and TNFalpha, may counteract the common idea of Ang-(1-7) agonists as a therapy concept in cardiac failure.
###end p 48
###begin p 49
###xml 280 284 280 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Rodgers1">[31]</xref>
###xml 286 290 286 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Ellefson1">[32]</xref>
###xml 870 874 870 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Eddy1">[33]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Inan1">[25]</xref>
###xml 1043 1047 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Segerer1">[34]</xref>
Nevertheless Ang-(1-7) and Mas' ability to stimulate inflammatory properties in the kidneys are undoubtedly from the data presented here. Although there were first indications for Ang-(1-7) to have such properties, because the peptide can increase the number of white blood cells [31], [32], we were interested in discovering more detailed mechanisms Mas and the heptapeptide may influence inflammatory processes. The recruitment of immune cells into the damaged kidney is a main feature of many renal diseases. These infiltrating inflammatory cells (monocytes/macrophages, T cells, and neutrophils) mediate the initiation and progression of damage by direct cytotoxicity, the secretion of soluble factors, such as proinflammatory cytokines, metalloproteinases, and growth factors, which modulate the local response and increase inflammation within the damage of kidney [33]. However, regulation renal inflammation is complex, involving activation of transcription factors and induction of chemokines and other proinflammatory mediators [25], [34]. Our data implicates that the proinflammatory properties of Ang-(1-7) and the Mas receptor in the kidney are primarily stimulated by a local activation of the NF-kappaB pathway, and the upregulation of proinflammatory genes under its control, like MCP-1 and IL-6, rather than by systemic effects as stimulating bone marrow-based progenitors of inflammatory cells. This conclusion is also supported by direct stimulating effects of the heptapeptide on cultured renal cells to stimulate the activation of NF-kappaB and related genes.
###end p 49
###begin p 50
###xml 398 402 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 404 408 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Segerer2">[35]</xref>
###xml 467 471 459 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Segerer3">[36]</xref>
Importantly, Ang-(1-7) stimulates proinflammatory factors independently from Ang II receptors. Furthermore, the absence of renal Mas significantly brakes their stimulation of NF-kappaB and downstream factors and blunts the stimulatory effects of Ang-(1-7). While some experimental studies based on the interference with chemokine expression or inhibition of NF-kappaB have shown beneficial effects [18], [35], under certain circumstances, this may worsen the disease [36]. For this reason other targets are needed for the treatment of renal diseases. Since Ang-(1-7) promotes and Mas deficiency inhibits disease progression in two independent experimental models, both are candidates for pharmacological intervention.
###end p 50
###begin p 51
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Mezzano1">[27]</xref>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-RodriguezIturbe1">[37]</xref>
As recent studies have demonstrated that several chronic kidney diseases, including diabetic nephropathy can be considered as inflammatory diseases [27], [37], our data may open a new avenue in the understanding of the genesis and disease progression due to the identification of two new key players in renal inflammation. As our data identify the lack/blockade of signaling of Mas as preventing renal inflammation, it may point to unique therapy strategies targeting the receptor and thus identified a promising new tool in preventing or delaying inflammatory renal diseases.
###end p 51
###begin title 52
Materials and Methods
###end title 52
###begin title 53
Animals
###end title 53
###begin p 54
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Walther1">[15]</xref>
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Gembardt1">[29]</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
Three-month old Mas-deficient mice [15] and their wild-type controls, both on a C57Bl/6 background, were used in the experiments. Independent sets of C57Bl/6 mice at the same age were used for the infusion experiments (saline or Ang-(1-7). Furthermore, mice deficient in all three Ang II receptors (AT1A, AT1B, AT2; triple knockouts) [29] and their own wild-type controls were used from the breeding colony of Thomas Walther at the FEM, Berlin, Germany. All animals were maintained under standardized conditions with an artificial 12-h dark-light cycle, with free access to food and water. Animals were killed by cervical dislocation, and kidneys were immediately removed and further processed for histological studies or frozen in liquid nitrogen for evaluation of RNA, protein and transcription factor activity. Control (saline-infused) animals and control animals without surgery (sham) of the same age were used as internal controls in all experimental settings. All animal studies were performed according to national guidelines and approved by the institutional animal care committees in Spain and Germany. This research was in compliance with the Guide for the Care and Use of Laboratory Animals published by the OPRR (Office for Protection against Research Risks) of the US National Institutes of Health, Washington, D.C. (NIH Publication No. 85-23, revised 1985).
###end p 54
###begin title 55
Unilateral ureteral obstruction (UUO)
###end title 55
###begin p 56
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 272 276 272 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 473 477 473 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Taneda1">[38]</xref>
###xml 14 18 <span type="species:ncbi:10090">mice</span>
###xml 93 97 <span type="species:ncbi:10090">Mice</span>
Mas-deficient mice (Mas-/-) and their age-matched wild-type controls (Mas+/+) underwent UUO. Mice were anesthetized by pentobarbital injection. The left ureter was ligated with silk (4/0) at two locations and cut between ligatures (obstructed kidney), as described before [18]. Contralateral kidneys served as controls. Animals were studied for 2, 5 and 7 days (n = 6-10 animals per genotype, per time point). Renal function was characterized as described before by others [38].
###end p 56
###begin title 57
Renal ischemia/reperfusion (I/R)
###end title 57
###begin p 58
###xml 95 96 95 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 99 100 99 100 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 523 529 <span type="species:ncbi:3635">cotton</span>
Mice were anesthetized by isoflurane inhalation. Anesthesia was maintained using a mixture of N2O/O2/isoflurane. Normal body temperature was maintained by placing the animals on heating pads until recovery from anesthesia. Following a midline abdominal incision, the left renal pedicle was localized and the renal artery and vein were dissected. An atraumatic micro-vascular clamp was placed, and the left kidney was occluded during 25 minutes. After inspection for signs of ischemia, the wound was covered with PBS soaked cotton and the animal was covered with a tin foil insulation sheet. After release of the clamp, restoration of blood-flow was inspected visually and a contra-lateral nephrectomy was performed. The excised right kidney was snap frozen and stored at -80degreesC for further analysis. The abdominal wound was closed in two layers using 5/0 sutures (B. Braun, Melsungen, Germany). The animals were given 0.5 ml PBS subcutaneously and placed under a heating lamp to recover from surgery.
###end p 58
###begin title 59
Peptide application in UUO and I/R
###end title 59
###begin p 60
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
Immediately following UUO or induction of renal ischemia-reperfusion injury, groups of animals were treated with Ang-(1-7) (15 microg/mouse per day) or saline by continuous subcutaneous infusion using osmotic minipumps (Alza Corp., Palo Alto, CA, USA) that were implanted between the scapula (n = 6-10 animals per group). Since Alzet pumps have a lag time of 2 hours before starting to release the peptide, we placed them in PBS solution 2 hours before implantation.
###end p 60
###begin title 61
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Systemic peptide infusion to healthy mice
###end title 61
###begin p 62
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 237 240 233 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 514 519 <span type="species:ncbi:10090">mouse</span>
The in vivo effect of Ang-(1-7) in the kidney was evaluated by systemic infusion of Ang-(1-7) (dissolved in saline) into mice (subcutaneously by osmotic minipumps, Alza Corp., Palo Alto, CA, USA), at the dose of 45 microg/mouse per day. Mas-deficient (Mas-/-), triple knockouts (TKO) and their wild-type controls (Mas+/+, TWT) underwent infusion for 5 days (n = 6-10 animals per group). In parallel sets, the Ang-(1-7) receptor was pharmacologically blocked using the specific Ang-(1-7) antagonist A779 (60 microg/mouse per day, by subcutaneous osmotic minipumps), starting 24 h before Ang-(1-7) infusion and during all the period of study (n = 6-10 animals per group). Peptides were provided by Bachem (Weil am Rhein, Germany).
###end p 62
###begin title 63
Renal histology and inflammatory cell infiltration
###end title 63
###begin p 64
###xml 198 202 198 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 204 208 204 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Walther3">[39]</xref>
###xml 294 298 294 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Padi1">[40]</xref>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
Paraffin sections of mouse tissues were prepared and stained using standard histology procedures, including hematoxylin/eosin (HE), Azan blue, Masson, Ladewig and van Gieson, as we described before [18], [39]. The protocol for periodic acid-Schiff (PAS) staining was adapted from Padi & Chopra [40]. The slides were deparafinized through xylene, and hydrated through graded ethanol. Finally, they have been examined by light microscopy.
###end p 64
###begin p 65
###xml 127 133 <span type="species:ncbi:10090">murine</span>
###xml 294 300 <span type="species:ncbi:9913">bovine</span>
###xml 324 328 <span type="species:ncbi:9925">goat</span>
Inflammatory cell infiltration was determined by monoclonal antibodies against F4/80 antigen (Serotec, Oxford, UK), present in murine monocytes/macrophages. Briefly, paraffin-embedded sections were rehydrated, their endogenous peroxidase blocked, and incubated for 1 hour at 25degreesC with 8% bovine serum albumin (BSA)/5% goat serum in phosphate-buffered saline (PBS) to eliminate nonspecific protein binding sites. The slides were then exposed (overnight, 4degreesC) to the monoclonal F4/80 antibody (dilution 1/50). After removing excess antibody, slides were treated with the corresponding anti-IgG biotinylated-conjugated antibody followed by the avidin-biotin-peroxidase complex (Dako, Dako Diagnosticos S.A, Barcelona, Spain), and 3,3'-diaminobenzidine as chromogen. Some tissue samples were incubated without the primary antibody or unrelated IgG, as negative controls.
###end p 65
###begin p 66
###xml 0 65 0 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">One method used to quantify infiltrating cells was image analysis</bold>
###xml 408 409 408 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 687 692 <span type="species:ncbi:10090">mouse</span>
One method used to quantify infiltrating cells was image analysis using a KZ 300 imaging system 3.0 (Zeiss, Munchen-Hallbergmoos, Germany). Briefly, the percentage of the stained area was calculated as the ratio of stained area and the total field area. For each sample, the mean staining area was obtained by analysis of 10 different fields (x200). The staining score is expressed as F4/80-positive cells/mm2. The immunohistochemistry experiments were performed in two kidney sections per experimental animal to obtain a mean score for each of them. In all cases, evaluations were performed by two independent observers in a blinded fashion and the mean score value calculated for each mouse.
###end p 66
###begin title 67
Stereological Analyses
###end title 67
###begin p 68
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Wreford1">[41]</xref>
###xml 566 570 566 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Wreford1">[41]</xref>
###xml 572 576 572 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-McLachlan1">[42]</xref>
The optical dissector method [41] was used to determine the total number of inflammatory cells per kidney. All estimates were performed using a 100x objective on an Olympus BX-50 microscope (Tokyo, Japan). The images were captured by a JVC TK-C1381EG (JVC, Yokohama, Japan) color video camera coupled to a Pentium PC computer. A software program, DH CASTGRID V1.10 (Olympus, Munich, Germany), was used to superimpose a set of unbiased counting frames on the video image. Fields were selected using a systematic uniform random sampling scheme as previously described [41], [42] using a computer-driven motorized stage (Multicontrol 2000; ITK, Lahnau, Germany). A microcator (Heidenhain D83301; Heidenhain, Traunreut, Germany) was attached to the microscope stage and monitored depth measurement.
###end p 68
###begin p 69
###xml 170 171 166 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 227 228 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
The leukocytes were identified based on their morphology and location within the renal cortex, medulla, and pelvis. The frame size for counting leukocytes was 2820 microm2. On the other hand, 4 frames with a total of 940 microm2 frame size were used to count glomerular injury (collapse, matrix deposition, thrombi). The difference in the number of fields and frame sizes depended on the frequency of the cells observed. Slides were masked prior to each type of quantification (cell number and apoptosis as outlined below) to facilitate unbiased counting.
###end p 69
###begin title 70
Cell Culture
###end title 70
###begin title 71
A. Conditions
###end title 71
###begin p 72
###xml 4 10 <span type="species:ncbi:10090">murine</span>
###xml 259 263 <span type="species:ncbi:9913">calf</span>
The murine tubuloepithelial cells (MCT cell line) were kindly donated by Dr. E.G. Neilson (Pennsylvania University, Philadelphia, PA, USA). Cells were cultured in petri-dishes with RPMI 1640 medium (BioWhitaker, Verviers, Belgium) supplemented with 10% fetal calf serum (FCS) and penicillin/glutamine (Gibco BRL, Paisley, Scotland, UK).
###end p 72
###begin title 73
B. Peptide treatments
###end title 73
###begin p 74
###xml 104 106 104 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;7</sup>
MCT cells were serum-depleted for 24 h and then stimulated during 18 h or 24 h with AngII or Ang(1-7) 10-7 mol/L (Bachem, Weil am Rhein, Germany), or TNF alpha 100 U/ml (Immunogenix corp., Los Angeles, CA, USA) in serum-free medium.
###end p 74
###begin title 75
C. Immune-fluorescence visualizing NF-kappaB translocation
###end title 75
###begin p 76
###xml 295 300 <span type="species:ncbi:9940">sheep</span>
###xml 373 379 <span type="species:ncbi:9986">rabbit</span>
###xml 439 444 <span type="species:ncbi:9940">sheep</span>
###xml 553 557 <span type="species:ncbi:9925">goat</span>
###xml 563 569 <span type="species:ncbi:9986">rabbit</span>
Immuno-fluorescence staining for p65 and p50 was done in MCT cells growing in coverslips. After stimulation, cells were washed with PBS, fixed in merckofix (Merck, Darmstadt, Germany) and treated with 0.1% Triton-X 100 for 1 minute on ice to permeabilize nuclear membranes and blocking with 10% sheep serum and 4% BSA in PBS for 1 hour. NF-kappaB subunits were detected by rabbit polyclonal anti-p65 or p50 antibodies (1:75 dilution in 4% sheep serum and 1% BSA in PBS; Santa Cruz Biotechnology, Inc, Santa Cruz, CA, U.S.A.) followed by FITC-conjugated goat anti-rabbit IgG antibody (1:100 dilution in 1% BSA in PBS). Nuclei were stained with propidium iodide (1 microg/ml) for 30 minutes. Coverslips were mounted in mowiol (Calbiochem, Merck KGaA. Biosciences, Darmstadt, Germany) and examined by a laser scanning confocal microscope (Leica Microsistemas, Alcobendas, Spain).
###end p 76
###begin title 77
Quantitative real-time PCR
###end title 77
###begin p 78
###xml 832 837 792 793 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#916;</bold>
###xml 1286 1287 1242 1243 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 255 276 <span type="species:ncbi:11786">murine leukemia virus</span>
Total RNA was isolated with Trizol (Gibco BRL, Paisley, Scotland, UK) with subsequent chloroform-isopropanol extraction according to the manufacturer's instructions. Two microg of RNA underwent random primed reverse transcription using a modified Maloney murine leukemia virus reverse transcriptase (Superscript II; Life Technologies, Gaithersburg, MD, USA) for 10 minutes at 25degreesC and 37degreesC for 2 hours. Proinflammatory gene expression was analyzed by real-time PCR, performed on an ABI Prism 7500 sequence detection PCR system (Applied Biosystems, Foster City, CA, USA) according to manufacturer's protocol. After an initial hold of 2 minutes at 50degreesC and 10 minutes at 95degreesC, the samples were cycled 40 times at 95degreesC for 15 seconds and 60degreesC for 60 seconds. For all quantitative cDNA analysis, the DeltaCt technique was applied. Assay IDs used were MCP-1, Mm00441242_m1 and IL-6, Mm00446190_m1. To normalize data different approaches were done using several housekeeping genes, including GAPDH, Histone-3 and 18 s ribosomal RNA expression (assay IDs: Mm99999915_g1 and Hs99999901_s). All primers, probes, and reagents were obtained from Applied Biosystems (Foster City, CA, USA). All measurements were performed in duplicate. Controls consisting of ddH2O were negative in all runs.
###end p 78
###begin title 79
Determination of NF-kappaB activity with electrophoretic mobility shift assay (EMSA)
###end title 79
###begin title 80
A. Protein extraction
###end title 80
###begin p 81
###xml 226 227 226 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 573 574 567 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 723 724 717 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 860 861 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1027 1028 1021 1022 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1149 1150 1143 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
For protein extraction from tissues, frozen kidney pieces were pulverized in a metallic chamber and resuspended in a cold extraction buffer [20 mmol/L HEPES-NaOH (pH 7.6), 20% (vol-vol) glycerol, 0.35 mol/L NaCl, 5 mmol/L MgCl2, 0.1 mmol/L EDTA, 1 mmol/L DTT, 0.5 mmol/L PMSF]. The homogenate was vigorously shaken for 30 minutes, and the insoluble materials precipitated by centrifugation at 40,000 g for 30 minutes at 4degreesC. For protein extraction from cultured cells, cells were resuspended in extraction buffer (10 mmol/L HEPES, pH 7.8, 15 mmol/L KCl, 2 mmol/L MgCl2, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol, 1 mmol/L PMSF) and homogenized. Nuclei and cytosolic fractions were separated by centrifugation at 1,000xg for 10 minutes. The nuclei were resuspended in extraction buffer to a final concentration of 0.39 mol/L KCl and centrifuged at 100,000xg for 30 minutes. Supernatants dialyzed overnight against a binding buffer containing 20 mmol/L HEPES-NaOH (pH 7.6), 20% (v/v) glycerol, 0.1 mmol/L NaCl, 5 mmol/L MgCl2, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol, and 0.5 mmol/L PMSF. The dialysates were cleared by centrifugation at 10,000xg for 15 minutes at 4degreesC and frozen at -80degreesC. Protein concentration was quantified by the bicinchoninic acid method (Pierce, Rockford, IL, USA).
###end p 81
###begin title 82
B. Electrophoretic mobility shift assay
###end title 82
###begin p 83
###xml 146 150 134 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005406-Esteban1">[18]</xref>
###xml 189 217 173 201 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-AGTTGAGGGGACTTTCCCAGGC-3&#8242;</named-content>
###xml 247 249 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 648 650 620 622 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
NF-kappaB activity was evaluated by binding of 60 microg of tissue extracts of tissue or 8-10 microg of nuclear extracts from cells, as described [18]. NF-kappaB consensus oligonucleotide (5'-AGTTGAGGGGACTTTCCCAGGC-3') was end-labeled with [gamma-32P]-ATP (Amersham, Buckinghamshire, UK) and T4 polynucleotide kinase (Promega, Madison, WI, USA). Samples were equilibrated for 10 minutes in a binding buffer [4% glycerol, 1 mmol/L MgCl2, 0.5 mmol/L EDTA, 0.5 mmol/L dithiothreitol, 50 mmol/L NaCl, 10 mmol/L Tris-HCl, pH 7.5, and 50 mg/ml of poly(dI-dC)] (Pharmacia LKB, Uppsala, Sweden), then the NF-kappaB consensus oligonucleotide labeled [gamma-32P]-ATP (0.35 pmol) was added and incubated for 20 minutes at room temperature.
###end p 83
###begin p 84
Negative controls without cellular extracts, and competition assays with a 100-fold excess of unlabeled NF-kappaB, mutant NF-kappaB and AP-1 (unrelated) oligonucleotides, were performed to establish the specificity of the reaction (not shown). When competition assays were done, the unlabeled probe was added to this buffer 10 minutes prior to the addition of the labeled probe. The results of EMSA experiments were analyzed using a Densitometer (GS-800, Biorad, Alcobendas, Madrid, Spain). The specificity of the antibodies was confirmed by Western blot. Oligonucleotides were from Promega Corp. (Madison, WI, USA). The reaction was stopped by adding gel-loading buffer (250 mmol/L Tris-HCL, 0.2% bromophenol blue, 0.2% xylene cyanol, and 40% glycerol) and protein-DNA complexes were separated on a nondenaturing, 4% acrylamide gel in Tris-borate. The gels were dried and exposed to X-ray film.
###end p 84
###begin title 85
Western blot analysis
###end title 85
###begin p 86
###xml 284 290 <span type="species:ncbi:9913">bovine</span>
Protein levels were assessed by Western blotting. Total proteins were resolved on 12% sodium dodecyl sulfate-polyacrylamide gels, electrophoretically transferred to polyvinylidene difluoride membranes, blocked (in buffer containing 0.01 mM Tris, pH 7.5, 0.4 M NaCl, 0.1% Tween-20, 1% bovine serum albumin, and 5% milk), and incubated for 18 h at 4degreesC with Bax and Bcl-xL antibodies (1:1000 and 1:500, respectively) (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Detection was performed with peroxidase-conjugated secondary antibody, using an ECL chemiluminescence kit (Amersham, Arlington Heights, IL, USA).
###end p 86
###begin title 87
Statistical analysis
###end title 87
###begin p 88
###xml 135 136 135 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 308 322 308 322 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">data not shown</bold>
###xml 361 362 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
Since all investigated parameters were normally distributed having continuous variables with equal variances, we analyzed with student t test or ANOVA. For UUO, all parameters investigated did not differ between contralateral kidneys and kidneys from control mice (without surgery) in each genotype studied (data not shown). Data are expressed as mean+/-SEM. A P<0.05 was considered significant. Tests were done using the SPSS 11.5 software package.
###end p 88
###begin p 89
###xml 18 19 18 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
We want to thank Ma Mar Gonzalez Garcia-Parreno and Helmut Wurdemann for technical help.
###end p 89
###begin title 90
References
###end title 90
###begin article-title 91
A public health action plan is needed for chronic kidney disease.
###end article-title 91
###begin article-title 92
Managing the burden of chronic kidney disease.
###end article-title 92
###begin article-title 93
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway.
###end article-title 93
###begin article-title 94
Renal and vascular hypertension-induced inflammation: role of angiotensin II.
###end article-title 94
###begin article-title 95
Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.
###end article-title 95
###begin article-title 96
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.
###end article-title 96
###begin article-title 97
Angiotensin I, angiotensin II and their biologically active peptides.
###end article-title 97
###begin article-title 98
Contribution of angiotensin-(1-7) to cardiovascular physiology and pathology.
###end article-title 98
###begin article-title 99
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.
###end article-title 99
###begin article-title 100
Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor.
###end article-title 100
###begin article-title 101
Cell type-specific expression of the Mas proto-oncogene in testis.
###end article-title 101
###begin article-title 102
The mas oncogene encodes an angiotensin receptor.
###end article-title 102
###begin article-title 103
The mas oncogene enhances angiotensin-induced [Ca2+]i responses in cells with pre-existing angiotensin II receptors.
###end article-title 103
###begin article-title 104
G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.
###end article-title 104
###begin article-title 105
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Sustained long term potentiation and anxiety in mice lacking the Mas protooncogene.
###end article-title 105
###begin article-title 106
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene.
###end article-title 106
###begin article-title 107
Obstructive nephropathy and renal fibrosis.
###end article-title 107
###begin article-title 108
Angiotensin II, via AT1 and AT2 receptors and NF-kappaB pathway, regulates the inflammatory response in unilateral ureteral obstruction.
###end article-title 108
###begin article-title 109
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction.
###end article-title 109
###begin article-title 110
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice.
###end article-title 110
###begin article-title 111
###xml 82 85 <span type="species:ncbi:10116">rat</span>
Angiotensin-(1-7) attenuates neointimal formation after stent implantation in the rat.
###end article-title 111
###begin article-title 112
###xml 93 97 <span type="species:ncbi:10116">rats</span>
Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats.
###end article-title 112
###begin article-title 113
###xml 59 63 <span type="species:ncbi:10116">rats</span>
Effects of angiotensin-(1-7) blockade on renal function in rats with enhanced intrarenal Ang II activity.
###end article-title 113
###begin article-title 114
###xml 29 33 <span type="species:ncbi:10116">rats</span>
Renal function in transgenic rats expressing an angiotensin-(1-7)-producing fusion protein.
###end article-title 114
###begin article-title 115
Pathological significance of renal expression of NF-kappa B.
###end article-title 115
###begin article-title 116
Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases.
###end article-title 116
###begin article-title 117
###xml 62 67 <span type="species:ncbi:9606">human</span>
NF-kappaB activation and overexpression of regulated genes in human diabetic nephropathy.
###end article-title 117
###begin article-title 118
Ischemic nephropathy: clinical characteristics and treatment.
###end article-title 118
###begin article-title 119
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors.
###end article-title 119
###begin article-title 120
Angiotensin-(1-7) binds to specific receptors on cardiac fibroblasts to initiate antifibrotic and antitrophic effects.
###end article-title 120
###begin article-title 121
Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy.
###end article-title 121
###begin article-title 122
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Synergistic effects of co-administration of angiotensin 1-7 and Neupogen on hematopoietic recovery in mice.
###end article-title 122
###begin article-title 123
Progression in chronic kidney disease.
###end article-title 123
###begin article-title 124
Role of chemokines for the localization of leukocyte subsets in the kidney.
###end article-title 124
###begin article-title 125
Chemokines and chemokine receptors in renal pathology.
###end article-title 125
###begin article-title 126
Chemokines in renal diseases.
###end article-title 126
###begin article-title 127
Role of inflammatory cells in the kidney in the induction and maintenance of hypertension.
###end article-title 127
###begin article-title 128
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Amelioration of diabetic nephropathy in SPARC-null mice.
###end article-title 128
###begin article-title 129
Accelerated mitochondrial adenosine diphosphate/adenosine triphosphate transport improves hypertension-induced heart disease.
###end article-title 129
###begin article-title 130
Selective angiotensin II type 1 receptor blockade ameliorates cyclosporine nephrotoxicity.
###end article-title 130
###begin article-title 131
Theory and practice of stereological techniques applied to the estimation of cell number and nuclear volume in the testis.
###end article-title 131
###begin article-title 132
Management of suboptimal cytologic smears. Persistent inflammatory smears.
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been supported by grants from the Nierstichting Nederland (C04.2103), Ministerio de Educacion y Ciencia (SAF 2005-03378), Comunidad de Madrid (11/BCB/016), Ministerio de Ciencia y Tecnologia (HA2004-0006), Ministerio de Sanidad (ISCIII-RETIC RD06/0016/0004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 134

